Eupraxia Pharmaceuticals Inc (EPRX) — Strategic Asset Allocation Index
Eupraxia Pharmaceuticals Inc (EPRX) has a Strategic Asset Allocation Index of 0.7% as of September 2025. Strategic assets (PP&E of CA$851.60K plus long-term investments of CA$-) total CA$851.60K, measured against net assets of CA$123.06 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Eupraxia Pharmaceuticals Inc Strategic Asset Allocation Index (2017–2024)
This chart shows how Eupraxia Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2024. As of September 2025, the index stands at 0.7%, representing strategic assets of CA$851.60K against net assets of CA$123.06 Million CAD. Explore Eupraxia Pharmaceuticals Inc cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Eupraxia Pharmaceuticals Inc (2017–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Eupraxia Pharmaceuticals Inc from 2017 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see EPRX company net worth.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.9% | CA$424.92K | CA$424.92K | CA$- | CA$45.77 Million | ▼ -37.8 pp |
| 2023 | 38.8% | CA$456.25K | CA$456.25K | CA$- | CA$1.18 Million | ▲ +32.7 pp |
| 2022 | 6.1% | CA$695.48K | CA$695.48K | CA$- | CA$11.36 Million | ▲ +3.1 pp |
| 2021 | 3.0% | CA$589.07K | CA$589.07K | CA$- | CA$19.55 Million | ▼ -5.2 pp |
| 2017 | 8.2% | CA$419.44K | CA$419.44K | CA$- | CA$5.11 Million | — |